The effect of sodium bicarbonate versus aluminum-magnesium hydroxide on postprandial gastric acid in duodenal ulcer patients
- PMID: 3018068
- DOI: 10.1097/00004836-198604000-00008
The effect of sodium bicarbonate versus aluminum-magnesium hydroxide on postprandial gastric acid in duodenal ulcer patients
Abstract
When ingested 1 hour after a meal, conventional liquid antacids have a buffering effect of approximately 2 hours, while in the fasting state their effect is brief, lasting less than 1 hour. We tested the hypothesis that equal doses of antacid, one water soluble (sodium bicarbonate) and the other water insoluble (aluminum hydroxide plus magnesium hydroxide, MaaloxR), would have similar durations of postprandial buffering if the water soluble antacid regenerates the particulate protein buffer of the meal that leaves the stomach more slowly than liquids. Tests were conducted in random order on three separate days in 10 patients with duodenal ulcer. The effects of 30 ml of 2.39 M sodium bicarbonate (6.17 g, about 1 teaspoonful), the aluminum-magnesium antacid, each equivalent to 71.7 mmol of in vitro buffer, and water as a control on pH, hydrogen ion activity, and titratable acidity were compared. Thirty milliliters of each was swallowed 1 and 3 hours after ingestion of a standard solid plus liquid. Compared to the water control each dose of sodium bicarbonate significantly increased intragastric pH and decreased hydrogen ion activity and titratable acidity for only 1 hour. Each dose of the aluminum-magnesium antacid significantly buffered intragastric contents for 2 hours. These findings indicate that sodium bicarbonate transiently buffers postprandial intragastric contents. Therefore, sodium bicarbonate fails to reconstitute the protein buffer of the meal effectively, and the observations suggest that it leaves the stomach rapidly with the liquid phase of the meal. However, the water insoluble, aluminum-magnesium antacid has a longer duration of buffering, probably because it leaves the stomach more slowly, largely with the solid portion of the meal.
Similar articles
-
Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.J Formos Med Assoc. 1998 Oct;97(10):704-10. J Formos Med Assoc. 1998. PMID: 9830281
-
Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.Pediatrics. 1986 Jul;78(1):55-7. Pediatrics. 1986. PMID: 3725503 Clinical Trial.
-
Cimetidine blocks antacid-induced hypergastrinemia.Gastroenterology. 1986 Jan;90(1):48-52. doi: 10.1016/0016-5085(86)90073-9. Gastroenterology. 1986. PMID: 3940254
-
Antacid therapy--changes in mineral metabolism.Scand J Gastroenterol Suppl. 1982;75:56-62. Scand J Gastroenterol Suppl. 1982. PMID: 6293043 Review.
-
Magaldrate and almasilate--complex buffering antacids.Drug Ther Bull. 1985 May 20;23(10):39-40. Drug Ther Bull. 1985. PMID: 3888581 Review. No abstract available.
Cited by
-
Antacids. Indications and limitations.Drugs. 1994 Feb;47(2):305-17. doi: 10.2165/00003495-199447020-00006. Drugs. 1994. PMID: 7512903 Review.
-
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria.Commun Biol. 2021 Jul 22;4(1):898. doi: 10.1038/s42003-021-02183-1. Commun Biol. 2021. PMID: 34294862 Free PMC article.
-
A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers.Therap Adv Gastroenterol. 2010 Jan;3(1):11-22. doi: 10.1177/1756283X09352095. Therap Adv Gastroenterol. 2010. PMID: 21180586 Free PMC article.
-
Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.BMC Microbiol. 2015 Mar 29;15:76. doi: 10.1186/s12866-015-0409-5. BMC Microbiol. 2015. PMID: 25879849 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources